Iambic Therapeutics, Inc.

Iambic Therapeutics, Inc. is a technology and clinical-stage life sciences company focused on integrating artificial intelligence with automated chemistry and biology experimentation to disrupt drug discovery paradigms. The company aims to improve the probability of success in drug discovery and development through its molecular superintelligence platform, which includes proprietary AI models and automated workflows.